Literature DB >> 8683148

TNF-alpha enhances colony-stimulating factor-1-induced macrophage accumulation in autoimmune renal disease.

K J Moore1, K Yeh, T Naito, V R Kelley.   

Abstract

The lpr mutation on the MRL background accelerates autoimmune nephritis in which macrophage (M phi) accumulation is prominent. Renal disease is absent in other strains with lpr. TNF-alpha and CSF-1 are increased in the kidney of MRL-lpr mice with loss of renal function. We have established that CSF-1 can incite renal injury in mice with the lpr mutation, and M phi from the MRL strain hyper-respond to this growth factor. We hypothesized that TNF-alpha enhanced the M phi response to CSF-1 in MRL-lpr mice. We now report that TNF-alpha enhanced CSF-1-induced bone marrow M phi proliferation in MRL-lpr mice, and not in congenic MRL +/+, normal C3H +/+, and BALB/c, or another strain with lpr (C3H-lpr). Using a gene transfer approach to deliver CSF-1 together with TNF-alpha into the kidney, we evaluated the impact on renal injury. Tubular epithelial cells genetically modified to produce CSF-1 (CSF-1-TEC) and TNF-alpha (TNF-TEC) placed under the renal capsule caused a greater accumulation of M phi in the implant site than CSF-1-TECs alone in MRL-lpr, but not MRL +/+ mice. We noted in tissues adjacent but not distal to the implanted TECs, an increase in M phi in the interstitium and surrounding glomeruli of MRL-lpr but not MRL +/+ mice. This indicated that CSF-1 and TNF-alpha released by TECs were responsible for promoting renal pathology. Taken together, these data suggest that the simultaneous expression of TNF-alpha and CSF-1 in the MRL-lpr kidney fosters M phi accumulation. We speculate that the increase in M phi in the kidney in response to CSF-1 and TNF-alpha is responsible for the rapid tempo of autoimmune renal injury in MRL-lpr mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683148

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Tumour necrosis factor and other cytokines in murine lupus.

Authors:  A N Theofilopoulos; B R Lawson
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

Authors:  Raimund Pichler; Maryam Afkarian; Brad P Dieter; Katherine R Tuttle
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-24

3.  IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis.

Authors:  Michiya Shinozaki; Junichi Hirahashi; Tatiana Lebedeva; Foo Y Liew; David J Salant; Ruth Maron; Vicki Rubin Kelley
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

4.  Sunlight triggers cutaneous lupus through a CSF-1-dependent mechanism in MRL-Fas(lpr) mice.

Authors:  Julia Menke; Mei-Yu Hsu; Katelyn T Byrne; Julie A Lucas; Whitney A Rabacal; Byron P Croker; Xiao-Hua Zong; E Richard Stanley; Vicki R Kelley
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

5.  Effective therapy for nephritis in (NZB x NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F.

Authors:  Xuelian Tao; Fred Fan; Victoria Hoffmann; Chun Y Gao; Nancy S Longo; Patricia Zerfas; Peter E Lipsky
Journal:  Arthritis Rheum       Date:  2008-06

6.  CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice.

Authors:  Julia Menke; Yasunori Iwata; Whitney A Rabacal; Ranu Basu; Yee G Yeung; Benjamin D Humphreys; Takashi Wada; Andreas Schwarting; E Richard Stanley; Vicki R Kelley
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

Review 7.  Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models.

Authors:  Simanta Pathak; Chandra Mohan
Journal:  Arthritis Res Ther       Date:  2011-09-30       Impact factor: 5.156

Review 8.  The role of inflammation in diabetic kidney disease.

Authors:  Su Woong Jung; Ju-Young Moon
Journal:  Korean J Intern Med       Date:  2021-07-01       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.